Victory for Mumia Abu-Jamal in Medical Treatment Case

Mumia

Mumia –Photo www.Sfbayview.com

Yesterday, Federal Judge Robert Mariani ordered the Pennsylvania Department of Corrections to immediately give Mumia Abu-Jamal the life-saving latest direct-acting antiviral medications that have a 95% cure rate.

After a year and a half of constant legal battling, near death hospitalization, and agonizing chronic sickness, Bret Grote of the Abolitionist Law Center and attorney Robert Boyle, and thousands of activists, on behalf of Mumia, have prevailed.

A message from Bret Grote attorney in  Abu-Jamal v. Wetzel: “Victory – late this afternoon Judge Robert Mariani of the federal court for the Middle District of Pennsylvania ordered officials from the Pennsylvania Department of Corrections to treat Mumia Abu-Jamal’s chronic hepatitis C with the latest direct-acting antiviral medications that have a 95% cure rate.

This is the first case in the country in which a federal court has ordered prison officials to provide an incarcerated patient with the new medications that came on the market in 2013. We expect an appeal, but for now this is a major victory.

Very honored to represent Mumia along with the impeccable Robert Boyle. Much gratitude to the family and friends and supporters of Mumia who have rallied and fought for his health and his freedom – Pam Africa, Johanna Fernandez, Suzanne Ross, Keith Cook, Wadiya Jamal, Noelle Harrahan and so many others. Hasta la victoria siempre!”

Message from Bob Boyle: “A Federal Judge in Pennsylvania has granted our request for a preliminary injunction requiring that the Pennsylvania DOC administer the hepatitis C anti-viral medication to political prisoner Mumia Abu Jamal. The struggle is far from over: the DOC will no doubt appeal this ruling. But a victory. Thanks to my co-counsel Bret Grote of the Abolitionist Law Center, Pam Africa and all the Mumia supporters and all of you.”

Mumia’s lawyers:

Bret Grote, Esq. Abolitionist Law Center
[email protected]

 

Robert Boyle, Esq
[email protected]

 

Leave a Reply

Your email address will not be published. Required fields are marked *